Recent Updates
Recently added Catalysts
MDAI Positive Sentiment Score: 75/100

Spectral AI to Participate in Upcoming Investor Conferences

Key Takeaway: Spectral AI, Inc. announced participation in upcoming investor conferences, including the H.C. Wainwright 26th Annual Global Investment Conference and Lake Street BIG8 Investor Conference. The company is focused on AI-based medical diagnostics to enhance treatment decisions in wound care, specifically targeting burns and diabetic foot ulcers. Their DeepView System is designed to provide immediate assessments of wound healing potential. This engagement seeks to garner interest in their innovative solutions while providing an update on the company's strategic direction.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in major investor conferences indicates active engagement with stakeholders.
  • The DeepView System offers innovative solutions for wound care management.
  • Potential for improved patient outcomes through AI-driven diagnostics.

Full Press Release Details

DALLAS, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that Peter M. Carlson, Chief Executive Officer, and Vince Capone, Chief Financial Officer, are scheduled to participate in the following investor conferences in New York City:
H.C. Wainwright 26th Annual Global Investment Conference
September 9 – 11, 2024
Virtual Fireside Chat will be available beginning September 9 at 7:00 am ET, by clicking here or by visiting the Investors section of Spectral AI’s website, here
1x1 meetings throughout the day
Lake Street BIG8 Investor Conference
1x1 meetings throughout the day
Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns and diabetic foot ulcers. The Company is working to revolutionize the management of wound care by “Seeing the Unknown®” with its DeepView System. The DeepView System is a predictive device that offers clinicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention. With algorithm-driven results and a goal to change the current standard of care, the DeepView System is expected to provide faster and more accurate treatment insight towards value care by improving patient outcomes and reducing healthcare costs. For more information about the DeepView System, visit www.spectral-ai.com.
Forward Looking Statements
Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s strategy, plans, objectives, initiatives and financial outlook. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements.
These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. As such, readers are cautioned not to place undue reliance on any forward-looking statements.
Investors should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” sections of the Company’s filings with the SEC, including the Registration Statement and the other documents filed by the Company. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements.

Frequently Asked Questions

What is Spectral AI focused on?

Spectral AI specializes in AI-driven medical diagnostics for enhanced wound care.

What conferences will Spectral AI attend in September 2024?

Spectral AI will attend the H.C. Wainwright and Lake Street BIG8 conferences.

What is the DeepView System?

The DeepView System is a device that assesses wound healing potential using algorithms.

Where can I find more information on DeepView?

More information about the DeepView System is available at www.spectral-ai.com.

What kind of patients does Spectral AI serve?

Spectral AI's initial applications target patients with burns and diabetic foot ulcers.

Last updated: Aug 28, 2024